(Q53854367)
Statements
Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines. (English)
Brian P Dolan
Kenneth D Gibbs
Suzanne Ostrand-Rosenberg
1 February 2006
176
3
1447-1455